Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia

被引:6
作者
Crespo-Lessmann, Astrid [1 ,2 ,3 ,4 ,5 ]
Curto, Elena [1 ,2 ,3 ]
Medina, Eder Freddy Mateus [1 ,2 ,3 ]
Palones, Esther [1 ,2 ,3 ]
Soler, Alicia Belda [1 ,2 ,3 ]
Maza, Soraya Sanchez [1 ,2 ,3 ]
Soto-Retes, Lorena [1 ,2 ,3 ]
Plaza, Vicente [1 ,2 ,3 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Neumol & Alergia, Barcelona, Spain
[2] Inst Invest Biomed St Pau, Barcelona, Spain
[3] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Serv Neumol & Alergia, Carrer Mas Casanovas 90, Barcelona 08041, Spain
[5] Alergia Hosp Santa Creu & St Pau, Carrer Mas Casanovas 90, Barcelona 08041, Spain
来源
JOURNAL OF ASTHMA AND ALLERGY | 2023年 / 16卷
关键词
asthma; sputum induction; phenotype; eosinophilia; EXHALED NITRIC-OXIDE; AIRWAY EOSINOPHILIA; BLOOD EOSINOPHILS; REFERENCE VALUES; DOUBLE-BLIND; MEPOLIZUMAB; BIOMARKERS; EXACERBATIONS; BENRALIZUMAB; MULTICENTER;
D O I
10.2147/JAA.S389402
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: The objectives of this study were, for patients attending a specialist asthma clinic at a tertiary care hospital, to determine, from sputum induction (SI), proportions of bronchial inflammatory phenotypes, demographic, clinical and functional characteristics of each phenotype, and the most accessible non-invasive inflammatory marker that best discriminates between phenotypes.Patients and Methods: Included were 96 patients with asthma, attending a specialist asthma clinic at a tertiary care hospital, who underwent testing as follows: SI, spirometry, fractional exhaled nitric oxide (FeNO), blood eosinophilia, total immunoglobulin E (IgE), and a skin prick test.Results: SI phenotypes were 46.9% eosinophilic, 33.3% paucigranulocytic, 15.6% neutrophilic, and 4.2% mixed. No significantly different clinical or functional characteristics were observed between the phenotypes. A positive correlation was observed between SI eosinophilia and both emergency visits in the last 12 months (p = 0.041; r = 0.214) and FeNO values (p = 0.000; r = 0.368). Blood eosinophilia correlated with SI eosinophilia (p = 0.001; r = 0.362) and was the best predictor of bronchial eosinophilia, followed by FeNO, and total blood IgE (area under the receiver operating characteristic curve (AUC-ROC) 72%, 65%, and 53%, respectively), although precision was only fair.Conclusion: In consultations for severe asthma, the most frequent phenotype was eosinophilic. Peripheral blood eosinophilia is a reliable marker for discriminating between different bronchial inflammatory phenotypes, is useful in enabling doctors to select a suitable biologic treatment and so prevent asthma exacerbation, and is a better predictor of bronchial eosinophilia than FeNO and IgE values.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 53 条
  • [1] Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma
    Abdo, Mustafa
    Pedersen, Frauke
    Kirsten, Anne-Marie
    Veith, Vera
    Biller, Heike
    Trinkmann, Frederik
    von Mutius, Erika
    Kopp, Matthias
    Hansen, Gesine
    Rabe, Klaus F.
    Bahmer, Thomas
    Watz, Henrik
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (06) : 1545 - +
  • [2] ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
    American Thoracic Society
    European Respiratory Society
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) : 912 - 930
  • [3] Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations
    Aziz-Ur-Rehman, Afia
    Dasgupta, Angira
    Kjarsgaard, Melanie
    Hargreave, Frederick E.
    Nair, Parameswaran
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
  • [4] Allergy diagnostic testing: An updated practice parameter
    Bernstein, I. Leonard
    Li, James T.
    Bernstein, David I.
    Hamilton, Robert
    Spector, Sheldon L.
    Tan, Ricardo
    Sicherer, Scott
    Golden, David B. K.
    Khan, David A.
    Nicklas, Richard A.
    Portnoy, Jay M.
    Blessing-Moore, Joann
    Cox, Linda
    Lang, David M.
    Oppenheimer, John
    Randolph, Christopher C.
    Schuller, Diane E.
    Tilles, Stephen A.
    Wallace, Dana V.
    Levetin, Estelle
    Weber, Richard
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) : S1 - S148
  • [5] The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma
    Berry, MA
    Shaw, DE
    Green, RH
    Brightling, CE
    Wardlaw, AJ
    Pavord, ID
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09) : 1175 - 1179
  • [6] Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    Bleecker, Eugene R.
    FitzGerald, J. Mark
    Chanez, Pascal
    Papi, Alberto
    Weinstein, Steven F.
    Barker, Peter
    Sproule, Stephanie
    Gilmartin, Geoffrey
    Aurivillius, Magnus
    Werkstrom, Viktoria
    Goldman, Mitchell
    [J]. LANCET, 2016, 388 (10056) : 2115 - 2127
  • [7] Eosinophils Target Therapy for Severe Asthma: Critical Points
    Brussino, L.
    Heffler, E.
    Bucca, C.
    Nicola, S.
    Rolla, G.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [8] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Busse, William W.
    Maspero, Jorge F.
    Rabe, Klaus F.
    Papi, Alberto
    Wenzel, Sally E.
    Ford, Linda B.
    Pavord, Ian D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Pirozzi, Gianluca
    Amin, Nikhil
    Akinlade, Bolanle
    Eckert, Laurent
    Chao, Jingdong
    Graham, Neil M. H.
    Teper, Ariel
    [J]. ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
  • [9] Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum
    Crespo, Astrid
    Giner, Jordi
    Torrejon, Montserrat
    Belda, Alicia
    Mateus, Eder
    Granel, Carmen
    Torrego, Alfons
    Ramos-Barbon, David
    Plaza, Vicente
    [J]. JOURNAL OF ASTHMA, 2016, 53 (05) : 459 - 464
  • [10] Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
    Demarche, Sophie F.
    Schleich, Florence N.
    Paulus, Virginie A.
    Henket, Monique A.
    Van Hees, Thierry J.
    Louis, Renaud E.
    [J]. RESPIRATORY RESEARCH, 2017, 18